| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adding a Reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenografts
|
Arvelo, F.
|
|
1995
|
31 |
11 |
p. 1862-1868
7 p.
|
artikel
|
| 2 |
Anaplastic large cell lymphoma (CD30+/Ki-1+). Analysis of 35 cases followed at GISL centres
|
Longo, G.
|
|
1995
|
31 |
11 |
p. 1763-1767
5 p.
|
artikel
|
| 3 |
A non-invasive test for the pre-cancerous breast
|
Simpson, H.W.
|
|
1995
|
31 |
11 |
p. 1768-1772
5 p.
|
artikel
|
| 4 |
Antibodies to LMP2A/2B in EBV-carrying malignancies
|
Lennette, E.T.
|
|
1995
|
31 |
11 |
p. 1875-1878
4 p.
|
artikel
|
| 5 |
A phase II study of carboplatin and hexamethylmelamine as induction chemotherapy in advanced epithelial ovarian carcinoma
|
Kristensen, G.B.
|
|
1995
|
31 |
11 |
p. 1778-1780
3 p.
|
artikel
|
| 6 |
Calendar of forthcoming meetings
|
|
|
1995
|
31 |
11 |
p. 1905-1910
6 p.
|
artikel
|
| 7 |
Cancer incidence in the Netherlands in 1989 and 1990: First results of the nationwide Netherlands cancer registry
|
Sanden, G.A.C.van der
|
|
1995
|
31 |
11 |
p. 1822-1829
8 p.
|
artikel
|
| 8 |
Childhood and adolescent cancer in Spain: Mortality time trends 1956–1990
|
Pollán, M.
|
|
1995
|
31 |
11 |
p. 1811-1821
11 p.
|
artikel
|
| 9 |
Clinical significance of serum S100 in metastatic malignant melanoma
|
Guo, Hua Bei
|
|
1995
|
31 |
11 |
p. 1898-1902
5 p.
|
artikel
|
| 10 |
Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients
|
Peng, B.
|
|
1995
|
31 |
11 |
p. 1804-1810
7 p.
|
artikel
|
| 11 |
Continuous infusion of vincristine, ifosfamide and epirubicin over 6 weeks in treatment-resistant advanced breast cancer
|
Gurney, H.
|
|
1995
|
31 |
11 |
p. 1773-1777
5 p.
|
artikel
|
| 12 |
Correction
|
|
|
1995
|
31 |
11 |
p. 1903-
1 p.
|
artikel
|
| 13 |
Disease monitoring by the tumour markers Cyfra 21.1 and TPA in patients with non-small cell lung cancer
|
van der Gaast, A.
|
|
1995
|
31 |
11 |
p. 1790-1793
4 p.
|
artikel
|
| 14 |
Dose intensification of carboplatin and etoposide as first-line combination chemotherapy in small cell lung cancer
|
Ellis, P.A.
|
|
1995
|
31 |
11 |
p. 1888-1889
2 p.
|
artikel
|
| 15 |
Enhancement of ACNU treatment of the BT4an rat glioma by local brain hyperthermia and intra-arterial drug administration
|
Schem, B.-C.
|
|
1995
|
31 |
11 |
p. 1869-1874
6 p.
|
artikel
|
| 16 |
EORTC early drug development meeting 1995, 21–24 June, Corfu, Greece
|
Lehnert, M.
|
|
1995
|
31 |
11 |
p. 1760-1762
3 p.
|
artikel
|
| 17 |
Factors affecting recurrence and progression in superficial bladder tumours
|
Kurth, K.H.
|
|
1995
|
31 |
11 |
p. 1840-1846
7 p.
|
artikel
|
| 18 |
Failure to confirm presence of SV40 sequences in human tumours
|
Krainer, M.
|
|
1995
|
31 |
11 |
p. 1893-
1 p.
|
artikel
|
| 19 |
Flow cytometric gating on cytokeratin-containing DNA aneuploid breast cancer cells improves the prediction of recurrence
|
Wingren, S.
|
|
1995
|
31 |
11 |
p. 1893-1895
3 p.
|
artikel
|
| 20 |
Genetic factors in the aetiology of malignant mesothelioma
|
Huncharek, M.
|
|
1995
|
31 |
11 |
p. 1741-1747
7 p.
|
artikel
|
| 21 |
Helping the relatives of patients with cancer
|
Fallowfield, L.
|
|
1995
|
31 |
11 |
p. 1731-1732
2 p.
|
artikel
|
| 22 |
Human stem cell factor protects CD34 positive human myeloid leukaemia cells from chemotherapy-induced apoptosis
|
Hassan, H.T.
|
|
1995
|
31 |
11 |
p. 1883-1884
2 p.
|
artikel
|
| 23 |
International cancer news
|
|
|
1995
|
31 |
11 |
p. 1723-1729
7 p.
|
artikel
|
| 24 |
International consensus panel on the treatment of primary breast cancer
|
Goldhirsch, A.
|
|
1995
|
31 |
11 |
p. 1754-1759
6 p.
|
artikel
|
| 25 |
Is the negative prognostic value of high oestrogen receptor (ER) levels in postmenopausal breast cancer patients due to a modified ER gene product?
|
Sancho-Garnier, H.
|
|
1995
|
31 |
11 |
p. 1851-1855
5 p.
|
artikel
|
| 26 |
Limited sampling models for reliable estimation of etoposide area under the curve
|
Holz, J.-B.
|
|
1995
|
31 |
11 |
p. 1794-1798
5 p.
|
artikel
|
| 27 |
lobaplatin in combination with methotrexate and vinblastine in patients with transitional cell carcinoma of the urinary tract—a pilot phase I/(II) study
|
Jung, P.
|
|
1995
|
31 |
11 |
p. 1891-1892
2 p.
|
artikel
|
| 28 |
Microsatellite instability in gastric carcinoma with special references to histopathology and cancer stages
|
Lin, J.-T.
|
|
1995
|
31 |
11 |
p. 1879-1882
4 p.
|
artikel
|
| 29 |
Pharmacokinetic modelling—A prelude to therapeutic drug monitoring for all cancer patients?
|
Judson, I.R.
|
|
1995
|
31 |
11 |
p. 1733-1735
3 p.
|
artikel
|
| 30 |
Phase II study of infusional cisplatin in combination with etoposide in the treatment of small cell lung cancer
|
Mori, K.
|
|
1995
|
31 |
11 |
p. 1781-1784
4 p.
|
artikel
|
| 31 |
p53 in malignant and benign liver lesions
|
Schaff, Zs.
|
|
1995
|
31 |
11 |
p. 1847-1850
4 p.
|
artikel
|
| 32 |
Problems with the evaluation of response after induction chemotherapy in breast cancer
|
Mannesse, C.K.
|
|
1995
|
31 |
11 |
p. 1886-1887
2 p.
|
artikel
|
| 33 |
Profile of T-cell lymphomas in Ibadan, Nigeria
|
Thomas, J.O.
|
|
1995
|
31 |
11 |
p. 1884-1885
2 p.
|
artikel
|
| 34 |
Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: Towards a novel surrogate test to monitor adjuvant therapies of solid tumours
|
Schlimok, G.
|
|
1995
|
31 |
11 |
p. 1799-1803
5 p.
|
artikel
|
| 35 |
Reversible neurotoxicity during interleukin-2 therapy for metastatic renal cell carcinoma
|
van Laar, J.M.
|
|
1995
|
31 |
11 |
p. 1895-1897
3 p.
|
artikel
|
| 36 |
Risk factors for the development of oesophageal cancer as a second primary tumour
|
van Halteren, H.K.
|
|
1995
|
31 |
11 |
p. 1836-1839
4 p.
|
artikel
|
| 37 |
Salvage chemotherapy in non-dysgerminomatous germ cell tumours of the ovary
|
Culine, S.
|
|
1995
|
31 |
11 |
p. 1890-1891
2 p.
|
artikel
|
| 38 |
Sequential chemotherapy, beta interferon, retinoids and tamoxifen in the treatment of metastatic breast cancer. A pilot study
|
Recchia, F.
|
|
1995
|
31 |
11 |
p. 1887-1888
2 p.
|
artikel
|
| 39 |
Spinal cord compression: From laboratory to clinic
|
Siegal, T.
|
|
1995
|
31 |
11 |
p. 1748-1753
6 p.
|
artikel
|
| 40 |
Splenic metastases in patients with portal hypertension
|
Pedrazzoli, P.
|
|
1995
|
31 |
11 |
p. 1885-1886
2 p.
|
artikel
|
| 41 |
Survival in interval breast cancer in the DOM screening programme
|
Brekelmans, C.T.
|
|
1995
|
31 |
11 |
p. 1830-1835
6 p.
|
artikel
|
| 42 |
The impact of cancer on key relatives: A comparison of relative and patient concerns
|
Harrison, J.
|
|
1995
|
31 |
11 |
p. 1736-1740
5 p.
|
artikel
|
| 43 |
The use of non-proven therapy among patients treated in norwegian oncological departments. A cross-sectional national multicentre study
|
Risberg, T.
|
|
1995
|
31 |
11 |
p. 1785-1789
5 p.
|
artikel
|
| 44 |
TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis
|
Thorlacius, S.
|
|
1995
|
31 |
11 |
p. 1856-1861
6 p.
|
artikel
|
Tijdschrift beschrijving